Speeding up the development process
Development of new medicines is a lengthy and laborious process. The time it takes from initial discovery of a working molecule to treating a patient is more than 10 years and more than 2,5 billion dollars. Just the clinical phase takes up more than 7 years in this process. If you are lucky… This long development and approval process is not only extremely expensive but also leads to a much slower adaptation of new treatments.
At this moment there are a lot of new approaches to speeding up the development process of new drugs. From parallelisation of development, AI to select the best candidates, organs on a chip or even detailed digital twins to calculate the effects of molecules on humans before they are really applied in reality.
The Molecule2Business 2023 event will dive into new approaches to speed up the process of bringing new pharmaceuticals to the market.
With keynotes from:
Nettie Buitelaar, director of Biotech Booster and Friso Smit, director of Oncode-PACT foundation. And parallel sessions on the state of art in the different stages of drug development (discovery, pre-clinical, and clinical). More information and abstracts of the different presenters will follow soon on the website.
Curious about the program? Click here!
Live event
This meeting is organised at Noviotech Campus in Nijmegen with networking, drinks & snacks afterwards.
Good to know
The progran finishes off with drinks & bites. This workshop is free of charge and facilitated in English. They welcome new contacts, so feel free to share this invite with your network! Please register upfront!
Be one of the first to register!
Source: SMB